Cialis will benefit from new indications

Published: 2012-05-25 07:00:00

Updated: 2012-05-25 07:00:00

The Korea Food and Drug Administration said Monday that it has approved Eli Lilly's Cialis 5 mg to treat men with symptoms of BPH alone or with both benign prostatic hyperplasia (BPH) symptoms and erectile dysfunction. The regulator's decision makes Cialis the first drug to offer this convenient ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK